get oral semaglutide for Weight Loss Semaglutide: High oral dosage may
Description
J Clin Endocrinol Metab 87 : 39974000 Purnell JQ et al
The OASIS 4 trial demonstrated 16.6% mean weight loss at 64 weeks with adherence, comparable to injectable Wegovy 2.4 mg ( The higher dose does not necessarily imply improved formulation efficiency
This mechanism of action mainly depends on the pancreatic islets The functional status of cells may not be effective in some patients with poor pancreatic island function
The hormonal interactions of these medications can play a significant role in addressing the unique challenges faced by perimenopausal women in managing their body composition
Calorie counting isnt necessary on Wegovy
